Igor Bluvstein was appointed as Chief Financial Officer at Revium Rx..
“On May 27, 2026, our Board of Directors appointed Mr. Igor Bluvstein to serve as the Chief Financial Officer of the Company and of its subsidiaries, effective immediately.”
Revium Rx. — fact timeline
Source-grounded facts extracted from Revium Rx.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Arie Gordashnikov resigned as Chief Financial Officer at Revium Rx..
“On May 27, 2026, Mr. Arie Gordashnikov resigned from his position as Chief Financial Officer of Revium Rx.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.